The global clinical oncology next generation sequencing (NGS) market size is expected to reach USD 1.5 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 13.2% over the forecast period. Rise in demand for personalized medicine, coupled with growth in next generation sequencing technology, is anticipated to accelerate the growth of NGS technology in clinical diagnostics.
Owing to the fact that next generation sequencing offers several advantages such as sensitivity, accuracy, and speed, this technology is anticipated to drive the oncology clinical diagnostics market. Furthermore, next generation sequencing aids in the assessment of multiple genes in a single assay, thereby eliminating the need to order several tests for determination of underlying mutation.
Request a sample Copy of the Global Clinical Oncology NGS Market Research Report @ https://www.grandviewresearch.com/industry-analysis/clinical-oncology-next-generation-sequencing-ngs-market/request/rs1
North America held the dominant share in the global the market for clinical oncology NGS in 2018 owing to increased focus of government bodies on cancer treatment, rise in healthcare expenditure, and presence of adequate infrastructure in the healthcare industry. Asia Pacific is expected to be the fastest-growing regional market throughout the forecast period majorly due to continuous reforms in the healthcare and pharmaceutical industries in the region. Presence of untapped markets in emerging economies in the region will also benefit regional growth.
Key suggestions from the report:
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/5503/ibb
Grand View Research has segmented the global clinical oncology NGS market on the basis of technology, workflow, application, end use, and region:
Clinical Oncology NGS Technology Outlook (Revenue, USD Million, 2014 – 2025)
Clinical Oncology NGS Workflow Outlook (Revenue, USD Million, 2014 – 2025)
Clinical Oncology NGS Application Outlook (Revenue, USD Million, 2014 – 2025)
Clinical Oncology NGS End-use Outlook (Revenue, USD Million, 2014 – 2025)
Clinical Oncology NGS Regional Outlook (Revenue, USD Million, 2014 – 2025)
Find more research reports on Biotechnology Industry, by Grand View Research:
Cell Sorting Market – The global cell sorting market size was valued at USD 405.47 million in 2018 and is expected to witness lucrative CAGR of 10.5% over the forecast period.
Protein Binding Assays Market – The protein binding assays market size was valued at USD 304.7 million in 2018 and is anticipated to grow at a CAGR of 10.6% over the forecast period.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/clinical-oncology-next-generation-sequencing-ngs-market